SGA was discovered to increase the cytotoxicity of cisplatin on lung cancer cells, decrease lung cancer cell proliferation and metastasis, and lower the tumor burden in lung cancer mice by blocking the TGF/FAK/PKB signaling pathway [32]. Here, PTK2 is linked to lung carcinoma.